What is bakuchiol and why compare it with retinol?

Bakuchiol is a plant-derived compound used in skincare marketed for the appearance of photoaged skin. It is chemically distinct from retinol; being compared in a study does not make the two substances the same molecule or members of the same chemical class. A useful comparison must state the products, schedules and outcomes studied rather than rely on the shorthand “natural retinol.” The clinical abstract by Dhaliwal and colleagues describes a prospective, randomized, double-blind comparison designed to evaluate common facial signs of photoaging and reported side effects, not to establish that any bakuchiol product can replace any retinoid regimen.

What did the clinical comparison actually do?

Forty-four participants were asked to apply either a 0.5% bakuchiol cream twice daily or a 0.5% retinol cream once daily for 12 weeks. High-resolution facial photographs were analysed at baseline and at weeks 4, 8 and 12. Participants answered tolerability questions; at visits, a dermatologist blinded to group assignment graded pigmentation and redness. The abstract reports that both groups had statistically significant reductions in wrinkle surface area and hyperpigmentation, and that it found no statistically significant difference between groups on those measures. Retinol users reported more scaling and stinging. These statements concern measured outcomes in these particular schedules and formulations. They should not be rewritten as “the two ingredients are equally effective,” because a study that fails to detect a difference is not necessarily designed or powered to prove equivalence.

What are the limits of that finding?

The number 44 describes people asked to use the regimens in the abstract; it is not evidence that hundreds of people, every skin tone, or every possible formulation were studied. The dose concentrations matched but frequency did not: bakuchiol was used twice daily and retinol once daily. Consequently this comparison cannot isolate molecular potency from regimen and formula in a way that would justify a universal one-for-one swap. Its 12-week endpoint is not a lifetime safety or durability assessment. Reported scaling and stinging were more frequent among retinol users in this trial, but that does not establish that bakuchiol never causes irritation. The abstract discusses facial photoaging measures, not treatment of a disease or a tested reduction in UV exposure.

What about pregnancy and sun protection?

The comparison discussed here did not study use during pregnancy or breastfeeding. Absence of such participants or outcomes is not affirmative evidence of safety in those situations; seek individualized healthcare advice rather than infer safety from botanical origin or from a comparison with retinol. Nor is a photoaging cream a replacement for UV protection. Choose a tested broad-spectrum sunscreen where appropriate, use it as directed and combine it with shade and protective clothing. An antioxidant marketing description is likewise not a surrogate for an SPF measurement. When evaluating a bakuchiol claim, ask whether it concerns wrinkles, pigmentation or tolerability, whether the finished formula resembles the one tested, and whether the claimed outcome was actually measured rather than inferred from the ingredient’s reputation.